SKQ1: a mitochondria-targeted antioxidant with therapeutic potential.
Abstract
Mitochondria-targeted antioxidants can selectively accumulate within mitochondria at low doses, thereby significantly enhancing therapeutic efficiency while minimising potential side effects. SKQ1, a novel mitochondria-targeted antioxidant, operates through a well-defined mechanism: a lipophilic cation enables mitochondrial targeting, while plastoquinone exerts antioxidant activity. SKQ1 primarily exerts its potent antioxidative effects by directly neutralising reactive oxygen species (ROS), thereby protecting mitochondrial function. Numerous studies have explored the biological functions of SKQ1, identifying its significant potential in anti-ageing, immune regulation, and antimicrobial activity. In this review, we summarise all available therapeutic evidence of SKQ1. We propose that SKQ1 represents a promising candidate for treating mitochondrial dysfunction-related diseases; however, its safety profile warrants further investigation.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
SKQ1 is proposed as a promising candidate for treating mitochondrial dysfunction-related diseases. The focus on mitochondrial function and oxidative stress directly relates to mechanisms of aging and potential interventions for longevity.
Author of this paper? Send a correction.